All In MedTech

Device Trial Radar · NCT07035925

Study Evaluating the Safety and Efficacy of an ECM Hydrogel for the Treatment of Anorectal Fistulas

Prospective Multi-Center, Single Arm, Study Evaluating the Safety and Efficacy of an ECM Hydrogel for the Treatment of Anorectal Fistulas

Last checked: Nov 20, 2026Latest source record: Mar 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

10

Planned (sponsor's estimate)

Start

Nov 24, 2025

Primary completion

Feb 24, 2027

Study completion Apr 24, 2028

Sponsor

Lead sponsor
ECM Therapeutics, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jun 25, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Safety and Efficacy of ECMT-100 for the Treatment of Anorectal Fistulas

Conditions

  • Fistula in Ano

Interventions

  • ECMT-100Device

    Colloidal hydrogel

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adverse EventsTime frame: 12 months from treatment

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Dartmouth Hitchcock Medical Center

    Lebanon, New Hampshire · Recruiting

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.